Developments in the Application of 1,2,3-Triazoles in Cancer Treatment
Background:
The impact of cancer on modern society cannot be emphasized enough in terms of both economic and human costs. Cancer treatments are known, unfortunately, for their side effects – frequently numerous and severe. Drug resistance is another issue medical professionals have to tackle when dealing with neoplastic illnesses. Cancer rates are rising worldwide due to various factors - low-quality nutrition, air and water pollution, tobacco use, etc. For those and many other reasons, drug discovery in the field of oncology is a top priority in modern medical science.
Objective:
To present the reader with the latest in cancer drug discovery with regard to 1,2,3-triazole- containing molecules in a clear, concise way so as to make the present review a useful tool for researchers.
Methods:
Available information present on the role of 1,2,3-triazoles in cancer treatment was collected. Data was collected from scientific literature, as well as from patents.
Results:
A vast number of triazole-containing molecules with antiproliferative properties have been proposed, synthesized and tested for anticancer activity both in vitro and in vivo. The substances vary greatly when considering molecular structure, proposed mechanisms of action and affected cancer cell types.
Conclusion:
Triazole-containing molecules with anticancer activity are being widely synthesized and extensively tested. They vary significantly in terms of both structure and mechanism of action. The methods for their preparation and administration are well established and with proven reproducibility. These facts suggest that triazoles may play an important role in the discovery of novel antiproliferative medications with improved effectiveness and safety profile.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Archiv der Pharmazie
6 publications, 8.96%
|
|
|
International Journal of Molecular Sciences
4 publications, 5.97%
|
|
|
Molecules
2 publications, 2.99%
|
|
|
Pharmaceutics
2 publications, 2.99%
|
|
|
Molecular Diversity
2 publications, 2.99%
|
|
|
Research on Chemical Intermediates
2 publications, 2.99%
|
|
|
Steroids
2 publications, 2.99%
|
|
|
Chemical Biology and Drug Design
2 publications, 2.99%
|
|
|
New Journal of Chemistry
2 publications, 2.99%
|
|
|
ChemistrySelect
2 publications, 2.99%
|
|
|
Frontiers in Chemistry
2 publications, 2.99%
|
|
|
Synthetic Communications
2 publications, 2.99%
|
|
|
Scientific Reports
2 publications, 2.99%
|
|
|
Applied Organometallic Chemistry
2 publications, 2.99%
|
|
|
RSC Advances
2 publications, 2.99%
|
|
|
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy
1 publication, 1.49%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 1.49%
|
|
|
Nanomaterials
1 publication, 1.49%
|
|
|
Frontiers in Pharmacology
1 publication, 1.49%
|
|
|
Chemical Papers
1 publication, 1.49%
|
|
|
Journal of Drug Delivery Science and Technology
1 publication, 1.49%
|
|
|
Journal of Molecular Structure
1 publication, 1.49%
|
|
|
Medicinal Research Reviews
1 publication, 1.49%
|
|
|
RSC Medicinal Chemistry
1 publication, 1.49%
|
|
|
ACS Omega
1 publication, 1.49%
|
|
|
Russian Journal of General Chemistry
1 publication, 1.49%
|
|
|
Carbohydrate Polymers
1 publication, 1.49%
|
|
|
Organic and Biomolecular Chemistry
1 publication, 1.49%
|
|
|
Environmental Toxicology
1 publication, 1.49%
|
|
|
Journal of Fluorine Chemistry
1 publication, 1.49%
|
|
|
1
2
3
4
5
6
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Wiley
16 publications, 23.88%
|
|
|
MDPI
11 publications, 16.42%
|
|
|
Elsevier
11 publications, 16.42%
|
|
|
Springer Nature
10 publications, 14.93%
|
|
|
Royal Society of Chemistry (RSC)
6 publications, 8.96%
|
|
|
Frontiers Media S.A.
3 publications, 4.48%
|
|
|
American Chemical Society (ACS)
2 publications, 2.99%
|
|
|
Pleiades Publishing
2 publications, 2.99%
|
|
|
Taylor & Francis
2 publications, 2.99%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.49%
|
|
|
The Russian Academy of Sciences
1 publication, 1.49%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.49%
|
|
|
Public Library of Science (PLoS)
1 publication, 1.49%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.